Abstract PO1-04-03: Phase I/II Trial of Ibrutinib Plus Trastuzumab in HER2-Positive Metastatic Breast Cancer - KIVIRID

Abstract PO1-04-03: Phase I/II Trial of Ibrutinib Plus Trastuzumab in HER2-Positive Metastatic Breast Cancer

Authors: Joyce O'Shaughnessy, Andrea Glidden, Tracy Locke, Amy Scales

Published: 2024-05-02

DOI: 10.1158/1538-7445.sabcs23-po1-04-03

Source: Full article

Abstract

Abstract